Patents Assigned to Nikken Sohonsha Corporation
  • Patent number: 11963485
    Abstract: A natural invasion promoting method that is environmentally friendly, easy to carry out, can cope with a wide range of areas and inclined surfaces, achieves efficient natural invasion, and can satisfactorily promote greening on a soil surface of interest, and a spraying material used in the method are provided. A natural invasion promoting method including: spraying a spraying material containing live algae on a soil surface; breeding the live algae; and also directly or indirectly catching flying seeds or spores by a tacky substance secreted on surfaces of the live algae or a catching structure composed of the live algae to promote greening on the soil surface.
    Type: Grant
    Filed: August 14, 2019
    Date of Patent: April 23, 2024
    Assignees: NIPPON KOEI CO., LTD., NIKKEN SOHONSHA CORPORATION
    Inventors: Mineto Tomisaka, Masaru Onodera, Fumiko Iwaki, Hisako Sanada, Taketo Nakano, Nobuo Mori, Ryo Sumi, Kanya Tokunaga
  • Publication number: 20220046868
    Abstract: A natural invasion promoting method that is environmentally friendly, easy to carry out, can cope with a wide range of areas and inclined surfaces, achieves efficient natural invasion, and can satisfactorily promote greening on a soil surface of interest, and a spraying material used in the method are provided. A natural invasion promoting method including: spraying a spraying material containing live algae on a soil surface; breeding the live algae; and also directly or indirectly catching flying seeds or spores by a tacky substance secreted on surfaces of the live algae or a catching structure composed of the live algae to promote greening on the soil surface.
    Type: Application
    Filed: August 14, 2019
    Publication date: February 17, 2022
    Applicants: NIPPON KOEI CO., LTD., NIKKEN SOHONSHA CORPORATION
    Inventors: Mineto TOMISAKA, Masaru ONODERA, Fumiko IWAKI, Hisako SANADA, Taketo NAKANO, Nobuo MORI, Ryo SUMI, Kanya TOKUNAGA
  • Patent number: 9180152
    Abstract: The invention is a method for treating psoriasis in a subject suffering from psoriasis. The method includes orally administering to the subject a pharmaceutically-effective amount of crude Dunaliella powder.
    Type: Grant
    Filed: December 5, 2010
    Date of Patent: November 10, 2015
    Assignees: NIKKEN SOHONSHA CORPORATION, TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
    Inventors: Aviv Shaish, Dror Harats, Shoshana Greenberger
  • Patent number: 8961993
    Abstract: Provided is a method for improving day photopic vision and/or cone-derived visual field and visual function in a subject suffering from a retinal disease or trauma including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. Also provided is a method for improving night vision and/or rod derived visual field in a subject suffering from a retinal disease including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. A pharmaceutical composition for improving day vision and/or visual field in a subject suffering from a retinal disease including crude Dunaliella powder is also provided.
    Type: Grant
    Filed: July 18, 2013
    Date of Patent: February 24, 2015
    Assignees: Nikken Sohonsha Corporation, Tel Hashomer Medical Research Infrastructure and Services Ltd.
    Inventors: Michael Belkin, Aviv Shaish, Dror Harats, Ygal Rotenstreich
  • Patent number: 8722057
    Abstract: In a step of producing a powder product of the alga belonging to the genus Dunaliella, a pH adjusting step is included in which an alga belonging to the genus Dunaliella is allowed to be in a basic state of pH 9.5 or higher. According to the method, it is possible to provide dried Dunaliella powder containing ?-carotene at a high content by suppressing degradation of ?-carotene as an active ingredient while decreasing each of the total pheophorbide amount and the existing pheophorbide amount to a predetermined value or less, even if the total pheophorbide amount and the existing pheophorbide amount of the cultured algae belonging to the genus Dunaliella are higher in summer.
    Type: Grant
    Filed: May 2, 2012
    Date of Patent: May 13, 2014
    Assignee: Nikken Sohonsha Corporation
    Inventors: Ami Ben-Amotz, Nobuo Mori
  • Publication number: 20140023702
    Abstract: Provided is a method for improving day photopic vision and/or cone-derived visual field and visual function in a subject suffering from a retinal disease or trauma including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. Also provided is a method for improving night vision and/or rod derived visual field in a subject suffering from a retinal disease including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. A pharmaceutical composition for improving day vision and/or visual field in a subject suffering from a retinal disease including crude Dunaliella powder is also provided.
    Type: Application
    Filed: July 18, 2013
    Publication date: January 23, 2014
    Applicants: TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD., NIKKEN SOHONSHA CORPORATION
    Inventors: Michael BELKIN, Aviv SHAISH, Dror HARATS, Ygal ROTENSTREICH
  • Patent number: 8529907
    Abstract: Provided is a method for improving day photopic vision and/or cone-derived visual field and visual function in a subject suffering from a retinal disease or trauma including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. Also provided is a method for improving night vision and/or rod derived visual field in a subject suffering from a retinal disease including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. A pharmaceutical composition for improving day vision and/or visual field in a subject suffering from a retinal disease including crude Dunaliella powder is also provided.
    Type: Grant
    Filed: April 27, 2009
    Date of Patent: September 10, 2013
    Assignees: Nikken Sohonsha Corporation, Tel Hashomer Medical Research Infrastructure and Services Ltd.
    Inventors: Michael Belkin, Aviv Shaish, Dror Harats, Ygal Rotenstreich
  • Patent number: 8343549
    Abstract: A method for treating a disease selected from diabetes mellitus and atherosclerosis, and a method for reducing triglycerides and/or increasing HDL cholesterol levels in the plasma of a subject. The method comprises administrating to a subject an effective amount of crude Dunaliella powder, optionally together with an activator of nuclear receptors.
    Type: Grant
    Filed: May 11, 2010
    Date of Patent: January 1, 2013
    Assignees: Nikken Sohonsha Corporation, Tel Hashomer Medical Research Infrastructure and Services Ltd.
    Inventors: Aviv Shaish, Dror Harats
  • Publication number: 20120288519
    Abstract: In a step of producing a powder product of the alga belonging to the genus Dunaliella, a pH adjusting step is included in which an alga belonging to the genus Dunaliella is allowed to be in a basic state of pH 9.5 or higher. According to the method, it is possible to provide dried Dunaliella powder containing ?-carotene at a high content by suppressing degradation of ?-carotene as an active ingredient while decreasing each of the total pheophorbide amount and the existing pheophorbide amount to a predetermined value or less, even if the total pheophorbide amount and the existing pheophorbide amount of the cultured algae belonging to the genus Dunaliella are higher in summer.
    Type: Application
    Filed: May 2, 2012
    Publication date: November 15, 2012
    Applicant: NIKKEN SOHONSHA CORPORATION
    Inventors: Ami BEN-AMOTZ, Nobuo MORI
  • Publication number: 20110045035
    Abstract: Provided is a method for improving day photopic vision and/or cone-derived visual field and visual function in a subject suffering from a retinal disease or trauma including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. Also provided is a method for improving night vision and/or rod derived visual field in a subject suffering from a retinal disease including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. A pharmaceutical composition for improving day vision and/or visual field in a subject suffering from a retinal disease including crude Dunaliella powder is also provided.
    Type: Application
    Filed: April 27, 2009
    Publication date: February 24, 2011
    Applicants: NIKKEN SOHONSHA CORPORATION, TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SEVICES LTD.
    Inventors: Michael Belkin, Aviv Shaish, Dror Harats, Ygal Rotenstreich
  • Patent number: 7790175
    Abstract: The present invention provides a new strain of turkey tail mushroom (Trametes versicolor (L.: Fr.) Pilat) having excellent biological activities (Accession number: FERM BP-10633). The strain is excellent in platelet aggregation inhibitory effect, chemokine gene expression inhibitory effect, antimutagenic effect, antitumor effect, antihypertensive effect, and immunomodulatory effect. The effect of the strain is enhanced synergistically by combining with microalgae and other basidiomycetes. The turkey tail mushroom of the present invention has high safety, and a possibility that a side effect is caused because of long-term continuous use is very low. Thus, it is useful for food/drink, cosmetics, pharmaceuticals or the like, the objective of which is the prevention and improvement in inflammation, allergy, tumor, and other diseases.
    Type: Grant
    Filed: July 28, 2006
    Date of Patent: September 7, 2010
    Assignee: Nikken Sohonsha Corporation
    Inventors: Fumio Eguchi, Ryo Sumi, Nobuo Mori
  • Publication number: 20100221348
    Abstract: A method for treating a disease selected from diabetes mellitus and atherosclerosis, and a method for reducing triglycerides and/or increasing HDL cholesterol levels in the plasma of a subject. The method comprises administrating to a subject an effective amount of crude Dunaliella powder, optionally together with an activator of nuclear receptors.
    Type: Application
    Filed: May 11, 2010
    Publication date: September 2, 2010
    Applicants: NIKKEN SOHONSHA CORPORATION, TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
    Inventors: Aviv SHAISH, Dror HARATS
  • Patent number: 7763255
    Abstract: A method for treating a disease selected from diabetes mellitus and atherosclerosis, and a method for reducing triglycerides and/or increasing HDL cholesterol levels in the plasma of a subject. The method comprises administrating to a subject an effective amount of crude Dunaliella powder, optionally together with an activator of nuclear receptors.
    Type: Grant
    Filed: July 10, 2007
    Date of Patent: July 27, 2010
    Assignees: Nikken Sohonsha Corporation, Tel Hashomer Medical Research Infrastructure and Services Ltd.
    Inventors: Aviv Shaish, Dror Harats
  • Publication number: 20100047269
    Abstract: The present invention provides a new strain of turkey tail mushroom (Trametes versicolor (L.: Fr.) Pilat) having excellent biological activities (Accession number: FERM BP-10633). The strain is excellent in platelet aggregation inhibitory effect, chemokine gene expression inhibitory effect, antimutagenic effect, antitumor effect, antihypertensive effect, and immunomodulatory effect. The effect of the strain is enhanced synergistically by combining with microalgae and other basidiomycetes. The turkey tail mushroom of the present invention has high safety, and a possibility that a side effect is caused because of long-term continuous use is very low. Thus, it is useful for food/drink, cosmetics, pharmaceuticals or the like, the objective of which is the prevention and improvement in inflammation, allergy, tumor, and other diseases.
    Type: Application
    Filed: July 28, 2006
    Publication date: February 25, 2010
    Applicant: NIKKEN SOHONSHA CORPORATION
    Inventors: Fumio Eguchi, Ryo Sumi, Nobuo Mori
  • Publication number: 20080019997
    Abstract: A method for treating a disease selected from diabetes mellitus and atherosclerosis, and a method for reducing triglycerides and/or increasing HDL cholesterol levels in the plasma of a subject. The method comprises administrating to a subject an effective amount of crude Dunaliella powder, optionally together with an activator of nuclear receptors.
    Type: Application
    Filed: July 10, 2007
    Publication date: January 24, 2008
    Applicants: NIKKEN SOHONSHA CORPORATION, TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
    Inventors: Aviv Shaish, Dror Harats
  • Patent number: 7264813
    Abstract: A method for treating a disease selected from diabetes mellitus and atherosclerosis, and a method for reducing triglycerides and/or increasing HDL cholesterol levels in the plasma of a subject. The method comprises administrating. to a subject an effective amount of crude Dunaliella powder, optionally together with an activator of nuclear receptors.
    Type: Grant
    Filed: September 24, 2003
    Date of Patent: September 4, 2007
    Assignees: Nikken Sohonsha Corporation, Tel Hashomer Medical Research Infrastructure and Services Ltd.
    Inventors: Aviv Shaish, Dror Harats
  • Patent number: 5948823
    Abstract: A method of protecting a mammal from the detrimental effects of irradiation is disclosed. The method comprises administering an effective amount of a substantially crude Dunaliella algae preparation to the mammal.
    Type: Grant
    Filed: September 9, 1997
    Date of Patent: September 7, 1999
    Assignees: Hadasit Medical Research Services & Development Company Ltd., Nikken Sohonsha Corporation
    Inventors: Ami Ben-Amotz, Zeev Weshler, Shaul Yatziv, Mordechai Sela